DOD Biotech PCL (BKK:DOD-F) Total Stockholders Equity : ฿1,058.2 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Total Stockholders Equity?

DOD Biotech PCL's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ฿1,058.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. DOD Biotech PCL's Book Value per Share for the quarter that ended in Mar. 2024 was ฿2.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. DOD Biotech PCL's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.15.

DOD Biotech PCL Total Stockholders Equity Historical Data

The historical data trend for DOD Biotech PCL's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Total Stockholders Equity Chart

DOD Biotech PCL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,219.36

1,214.06

1,280.56

887.15

1,057.94

DOD Biotech PCL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															872.40	1,037.11	1,049.12	1,057.94	1,058.20

DOD Biotech PCL (BKK:DOD-F) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

DOD Biotech PCL's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1058.195	-	0)	/	450.414
	=	2.35

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

DOD Biotech PCL's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(102.669	+	52.579)	/	1058.195
	=	0.15

DOD Biotech PCL Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL (BKK:DOD-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-F) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No.111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is engaged in the business of food supplements and health drinks of all kinds. The company offers Skincare products, Dietary supplements, Healthy supplements, and Own branded products. The majority of the company's revenue is derived from the supplementary business segment within Thailand. The segments of the group are Supplementary business, Manufacturing cosmetic and Network marketing, Manufacturing Extraction business, and others, of which a majority of revenue is derived from the Supplementary business segment.

DOD Biotech PCL (BKK:DOD-F) Headlines

No Headlines